166 related articles for article (PubMed ID: 35400349)
1. Targeting Signaling Pathway by Curcumin in Osteosarcoma.
Farnood PR; Pazhooh RD; Asemi Z; Yousefi B
Curr Mol Pharmacol; 2023; 16(1):71-82. PubMed ID: 35400349
[TBL] [Abstract][Full Text] [Related]
2. Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma.
Lu KH; Lu PW; Lu EW; Lin CW; Yang SF
Int J Biol Sci; 2023; 19(4):1241-1265. PubMed ID: 36923933
[TBL] [Abstract][Full Text] [Related]
3. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
Leow PC; Bahety P; Boon CP; Lee CY; Tan KL; Yang T; Ee PL
Eur J Med Chem; 2014 Jan; 71():67-80. PubMed ID: 24275249
[TBL] [Abstract][Full Text] [Related]
4. Curcumin in human osteosarcoma: From analogs to carriers.
Lu KH; Lu PW; Lin CW; Yang SF
Drug Discov Today; 2023 Feb; 28(2):103437. PubMed ID: 36372327
[TBL] [Abstract][Full Text] [Related]
5. Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers.
Gota VS; Maru GB; Soni TG; Gandhi TR; Kochar N; Agarwal MG
J Agric Food Chem; 2010 Feb; 58(4):2095-9. PubMed ID: 20092313
[TBL] [Abstract][Full Text] [Related]
6. The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art.
Zahedipour F; Bolourinezhad M; Teng Y; Sahebkar A
J Oncol; 2021; 2021():3006853. PubMed ID: 34671398
[TBL] [Abstract][Full Text] [Related]
7. Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway.
Aziz MNM; Hussin Y; Che Rahim NF; Nordin N; Mohamad NE; Yeap SK; Yong CY; Masarudin MJ; Cheah YK; Abu N; Akhtar MN; Alitheen NB
Molecules; 2018 Jan; 23(1):. PubMed ID: 29303982
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.
Ma Y; Ren Y; Han EQ; Li H; Chen D; Jacobs JJ; Gitelis S; O'Keefe RJ; Konttinen YT; Yin G; Li TF
Biochem Biophys Res Commun; 2013 Feb; 431(2):274-9. PubMed ID: 23291185
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling.
Li Y; Zhang J; Ma D; Zhang L; Si M; Yin H; Li J
FEBS J; 2012 Jun; 279(12):2247-59. PubMed ID: 22521131
[TBL] [Abstract][Full Text] [Related]
10. Molecular Signaling Pathways as Potential Therapeutic Targets in Osteosarcoma.
Dana PM; Sadoughi F; Asemi Z; Yousefi B
Curr Med Chem; 2022; 29(25):4436-4444. PubMed ID: 35139778
[TBL] [Abstract][Full Text] [Related]
11. Schisandrin B suppresses osteosarcoma lung metastasis
Wang Y; Chen J; Huang Y; Yang S; Tan T; Wang N; Zhang J; Ye C; Wei M; Luo J; Luo X
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029287
[TBL] [Abstract][Full Text] [Related]
12. Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy.
Angulo P; Kaushik G; Subramaniam D; Dandawate P; Neville K; Chastain K; Anant S
J Hematol Oncol; 2017 Jan; 10(1):10. PubMed ID: 28061797
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.
Leow PC; Tian Q; Ong ZY; Yang Z; Ee PL
Invest New Drugs; 2010 Dec; 28(6):766-82. PubMed ID: 19730790
[TBL] [Abstract][Full Text] [Related]
14. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells.
Lee DS; Lee MK; Kim JH
Anticancer Res; 2009 Dec; 29(12):5039-44. PubMed ID: 20044614
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic effects of curcumin on human osteosarcoma U2OS cells.
Jin S; Xu HG; Shen JN; Chen XW; Wang H; Zhou JG
Orthop Surg; 2009 May; 1(2):144-52. PubMed ID: 22009832
[TBL] [Abstract][Full Text] [Related]
16. The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway.
Hamzehzadeh L; Atkin SL; Majeed M; Butler AE; Sahebkar A
J Cell Physiol; 2018 Oct; 233(10):6530-6537. PubMed ID: 29693253
[TBL] [Abstract][Full Text] [Related]
17. Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.
Li ZZ; Wang YL; Yu YH; Xing YL; Ji XF
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):105-112. PubMed ID: 30657552
[TBL] [Abstract][Full Text] [Related]
18. Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation.
Hu S; Chang J; Ruan H; Zhi W; Wang X; Zhao F; Ma X; Sun X; Liang Q; Xu H; Wang Y; Yang Y
Int J Biol Sci; 2021; 17(10):2504-2522. PubMed ID: 34326690
[No Abstract] [Full Text] [Related]
19. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
[TBL] [Abstract][Full Text] [Related]
20. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
